The cause of the patients presentation at this point was unclear but the diarrhea and dehydration gradually became worse. obstruction. Moreover, normal duplex ultrasound imaging of liver vasculature and her unusual presentation led to a delay in her diagnosis highlighting the need for an increased index of suspicion. toxin, ova and parasites, and enteric viruses. PLE was confirmed by persistent elevation of fecal A1AT, with a maximum value of 960 mg/dL (normal 55 mg/dL). A hepatic duplex ultrasound demonstrated gross ascites and patent hepatic vasculature without evidence of splenomegaly. A CT scan of the abdomen and the pelvis revealed stable lymphadenopathy. An echocardiogram was unremarkable. Upper gastrointestinal endoscopy revealed grade 1 esophageal varices, unremarkable mucosal biopsies, no lymphangiectasia, and normal disaccharidase assays. Colonoscopy was unremarkable as were multiple colonic mucosal biopsies. An endocrinology workup was normal, including normal thyroid function Baricitinib (LY3009104) tests (TSH 2.81 uIU/mL), serum gastrin, 24-hour urine catecholamines, and urine 5-HIAA. The cause of the patients presentation at this point was unclear but the diarrhea and dehydration gradually became worse. She was dependent on parenteral nutrition and albumin infusions to maintain stable hemodynamical status. The patient also had persistently positive tests for Epstein-Barr virus in plasma by polymerase chain reaction; however, subsequent investigations including bone marrow biopsy, enteroscopy, and liver biopsy demonstrated no evidence of post-transplant lymphoproliferative disorder. Because of ongoing symptoms of diarrhea and abdominal distention, further investigations were conducted. An enteroscopy was done that showed grade 2 esophageal varices, but was otherwise unremarkable including showing no intestinal lymphangiectasia. A liver biopsy conducted at the same time revealed marked zone 3 sinusoidal congestion and significant centrilobular hepatocyte dropout (Fig. 1) raising the possibility of vascular outflow abnormalities. To investigate this possibility, a transjugular hepatic venogram was conducted. Because the hepatic vein could not be accessed from the transjugular approach, percutaneous access into a peripheral hepatic vein was achieved, and a stricture at the anastomosis site between the hepatic vein-inferior cava was identified (Fig. 2) with HV-RA pressure gradient being 18 mmHg (normal 5 mmHg or less); balloon venoplasty reduced the HV-RA gradient to 4 mmHg. There was no improvement in symptoms at one wk after the venoplasty; therefore, a repeat venogram was conducted which showed marked stenosis at the same site, once Baricitinib (LY3009104) again with a reduction in HV-RA gradient to 5 mmHg after balloon venoplasty. Open in a separate window Fig. 1 Liver biopsy showing coagulative necrosis around the central vein (*) and sinusoidal dilatation. Original photomicrographs obtained with 4 (a) and 20 (b) objectives. Open in a separate window Fig. 2 Venogram pre-venoplasty (a) and post-venoplasty (b). Immediately after the second session of balloon venoplasty, the diarrhea and ascites improved. She was able to tolerate enteral feeds and parenteral nutrition was Rabbit Polyclonal to SGCA discontinued. Her serum albumin Baricitinib (LY3009104) and fecal A1AT normalized (Fig. 3) and she was discharged from hospital. However, within two months she began to have diarrhea again, with hypoalbuminemia and re-accumulation of ascitic fluid. Repeat venoplasty with reduction of the HV-RA gradient was performed which once again led to an improvement in the patients symptoms. Recurrence of persistent diarrhea and ascites was an indication for a total of six sessions of balloon venoplasty in this case. Open in a separate window Fig. 3 Chart showing the trend of weight, Baricitinib (LY3009104) albumin and fecal A1AT after liver transplantation and venoplasty. Discussion Vascular complications are a well-known complication of liver transplantation, especially in children, being most common in the portal vein and hepatic artery (1, 2). HVOO following liver transplantation is less common, with Baricitinib (LY3009104) an incidence reported between 1% and 7% (3). This often occurs in the early post-operative period (2), possibly from direct compression of the vein, but can occur several months to years later (1), from fibrotic changes in the anastomotic site (3). In a single research, ascites was the most frequent clinical indication of HVOO pursuing pediatric liver organ transplantation (4). PLE can be a very uncommon problem of BuddCChiari symptoms (5), despite having second-rate vena cava blockage (6). To your knowledge, there possess just been two reported instances of PLE supplementary to HVOO pursuing liver organ transplantation, one inside a 42-yr-old male (7), and.